# Sugammadex-Induced Clenching During Neuromuscular Blockade Reversal

> **NCT06962007** · NA · COMPLETED · sponsor: **Wonkwang University Hospital** · enrollment: 240 (actual)

## Conditions studied

- Neuromuscular Blockade Reversal Agent
- Perioperative Complications
- Anesthesia, General
- Sugammadex
- Monitoring, Intraoperative
- Masseter Muscle Spasm

## Interventions

- **DRUG:** Sugammadex 1 mg/kg Group
- **DRUG:** Sugammadex 2 mg/kg Group
- **DRUG:** Sugammadex 4 mg/kg Group
- **DRUG:** Pyridostigmine/Glycopyrrolate Group

## Key facts

- **NCT ID:** NCT06962007
- **Lead sponsor:** Wonkwang University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-05-01
- **Primary completion:** 2025-05-20
- **Final completion:** 2025-07-14
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2025-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06962007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06962007, "Sugammadex-Induced Clenching During Neuromuscular Blockade Reversal". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06962007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*